Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells

• Cestmir Altaner ,

  * E-mail: exonalt@savba.sk (CA); madaricjuraj@gmail.com (JM)

  Affiliations Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia, St. Elisabeth Cancer Institute, Bratislava, Slovakia

  ⨯
• Veronika Altanerova,

  Affiliations Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia, St. Elisabeth Cancer Institute, Bratislava, Slovakia

  ⨯
• Marina Cihova,

  Affiliation Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia

  ⨯
• Lubica Hunakova,

  Affiliation Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia

  ⨯
• Katarina Kaiserova,

  Affiliation St. Elisabeth Cancer Institute, Bratislava, Slovakia

  ⨯
• Andrej Klepanec,

  Affiliation National Cardiovascular Institute, Bratislava, Slovakia

  ⨯
• Ivan Vulev,

  Affiliation National Cardiovascular Institute, Bratislava, Slovakia

  ⨯
• Juraj Madaric

  * E-mail: exonalt@savba.sk (CA); madaricjuraj@gmail.com (JM)

  Affiliations National Cardiovascular Institute, Bratislava, Slovakia, Slovak Medical University, Bratislava, Slovakia

  ⨯